Charles Evan Ballantyne

Insider Reports History

Entity
Individual
Location
27 Hearthstone Road, Hopkinton, MA
Signature
/s/ Cathy Rude, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Evan Ballantyne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 100K $586K $5.86 Apr 10, 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 50K $125K $2.50 Apr 10, 2023 Direct

Insider Reports Filed by Charles Evan Ballantyne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Apr 10, 2023 2 $0 4 Apr 12, 2023 Chief Financial Officer
GANX Gain Therapeutics, Inc. Apr 10, 2023 0 $0 3 Apr 12, 2023 Chief Financial Officer